Supplements & Wellness Brand Benchmarks 2026

Supplements are built for repeat purchase. In Decile's June 2024 data, 37.67% of supplement customers repurchased within about 3 months of their first order (Q1 2024 cohort, up from 33.15% a year earlier). Add high gross margins from low COGS and natural subscription mechanics, and the unit economics look hard to beat. The catch: regulatory compliance costs, platform advertising restrictions on health claims, and customer acquisition in a crowded market compress the advantage faster than expected.

These benchmarks are built from aggregated data across Finaloop (P&L benchmarks, 2024 data, hundreds of 7- and 8-figure brands), First Page Sage (CAC data, 80+ ecommerce clients, 2020-2025), Decile and BS&Co (repurchase data) and Ecom CFO (EBITDA percentiles). If you run a supplements or wellness brand at $5M to $75M, these are the numbers to measure against.

The Retention Advantage

Decile's 37.67% (repurchase within about 3 months of the first order, Q1 2024 cohort) covers supplements only, so it can't be ranked against other categories. For a like-for-like comparison, BS&Co's agency data (Feb 2026, 156,110 customers) uses one 365-day window across categories: 22-44% of customers in consumables placed a second order, against 10-17% in fashion and 7-18% in durables and home.

The windows differ, so only compare figures within the same dataset.

This matters because repurchase rate is the single biggest lever on LTV, and LTV drives how much you can afford to spend on acquisition. A supplement brand with strong repeat and a subscription option has a structural economic advantage over a fashion brand, so supplements should produce stronger LTV:CAC ratios than most consumer categories. When they do not, the problem is almost always on the acquisition side. If your LTV:CAC is below 3:1 with a 35%+ three-month repurchase rate, that is a clear signal: your retention economics are working and your acquisition is not. The next step is channel-level CAC tracking to find where the overspend is.

Subscription Economics

Supplements are the most natural subscription category in ecommerce. The product runs out on a predictable schedule (30, 60, or 90 days), the customer wants the same product again, and the reorder decision has low friction. This creates three specific economic advantages:

• Lower effective CAC. Acquisition cost is amortized over more orders. A $60 CAC spread over 8 subscription orders (2 years at quarterly refills) is an effective $7.50 per order, compared to $60 for a one-time buyer.
• Higher LTV. A subscription customer on a 90-day cycle at $45 per order generates $180 per year and $360 over 24 months. A one-time buyer generates $45.
• Predictable cash flow. Subscription revenue is recurring and forecastable, which improves cash planning and reduces the risk of inventory mismatches.

The key metric for subscription brands is subscription retention rate: what percentage of subscribers are still active at 6, 12, and 24 months. A brand adding 1,000 subscribers per month but losing 800 nets only 200: a churn problem that no amount of acquisition spending can fix. The retention curve is the single most important chart in a supplement business.

Gross Margin

Supplements usually carry high gross margins because COGS is low relative to retail price, and contract manufacturing at scale drives per-unit costs down further. But there is no reliable public gross-margin benchmark for the category, so measure against your own history, by channel and by product.

A high gross margin comes with a caveat. Supplement brands often need to reinvest a larger share of gross profit into customer acquisition and compliance than other categories. A 75% gross margin that requires spending 35% of revenue on paid acquisition and 5-8% on regulatory compliance nets out to a contribution margin closer to other categories than the headline gross margin suggests. The high COGS margin can mask bad decisions elsewhere in the P&L, so the operating discipline is to track contribution margin as tightly as gross margin. If your gross margin is above 65% but your EBITDA is below 7%, that gap is where the diagnosis lives. Pull your marketing spend and compliance costs as separate line items to find it.

Contribution Margin

Finaloop, 2024 data, hundreds of 7- and 8-figure brands. Its contribution margin is gross profit after shipping, fulfillment and payment fees, minus variable ad spend. Below 20% is the line I use for red.

For supplement brands, the spread between gross margin and contribution margin is usually driven by two factors: marketing spend and fulfillment costs. Supplements are lightweight and non-fragile (low shipping costs), so fulfillment is a smaller drag than categories like beverages or furniture. The bigger variable is acquisition spending, which tends to run higher in supplements due to platform restrictions on health claims and intense competition.

EBITDA Margin

Medians are Finaloop's 2024 data across all categories. For scale, 15-20% is roughly top-5% territory: Ecom CFO's 95th percentile for $10M-$50M brands was 17.51% in FY2025 (18 brands).

Supplement brands should produce higher EBITDA margins than most consumer categories given their gross margin advantage. The ones that do not usually have one of three problems: over-hiring (G&A bloat from building a team sized for $50M when the brand is doing $15M), a compliance cost burden that was never budgeted as a line item, or an acquisition cost structure that eats the margin advantage because the brand spread across too many paid channels before optimizing the core two. If you are a supplement brand with 70%+ gross margin and sub-10% EBITDA, the operating exercise is to list every cost between gross profit and EBITDA, rank them by size, and ask which three you would cut if revenue dropped 20% tomorrow. Those three are your priority regardless.

LTV:CAC Ratio

These bands are rules of thumb: no public DTC LTV:CAC benchmark has a stated sample. 3:1 is the common rule and below 2:1 is a warning sign; the 4:1 line is mine.

Supplements should be one of the strongest LTV:CAC categories given their repeat rates and subscription mechanics. The rule of thumb is 3:1 minimum, measured over a 36-month customer window (not an unfalsifiable "lifetime" assumption). Subscription models extend customer lifetime, so well-run supplement brands should clear that bar with room to spare. If your LTV:CAC is below 3:1 in supplements, the issue is almost always acquisition efficiency. The deeper issue is usually brand differentiation: in a crowded category, the brands that keep CAC manageable are the ones with a clear point of view that the customer can describe in one sentence. Generic formulations with generic positioning produce generic CAC.

What Good Looks Like

Warning Signs

A strong gross margin with weak EBITDA is the gap the 90-Day Profit Sprint is built to diagnose: find where profit is going, choose three changes and put them to work over 90 days.

Category-Specific Insights

1. Regulatory compliance is a real cost center, not an afterthought

FDA requirements for dietary supplements include current Good Manufacturing Practices (cGMP), adverse event reporting, and specific labeling requirements. FTC scrutinizes health claims in advertising. Third-party testing (NSF, USP, or equivalent) adds credibility but also cost. A supplement brand at scale should budget $50K-$200K+ annually for compliance-related costs including testing, legal review, and claim substantiation. Founders who treat this as a cost to defer are building on a foundation that a single FDA warning letter can crack.

2. Platform advertising restrictions change the acquisition playbook

Meta and Google both restrict health claims in supplement advertising. This limits the creative and targeting options available to supplement brands compared to fashion or beauty. The brands that succeed at acquisition work around these restrictions through educational content, influencer partnerships, and organic SEO that drives traffic to owned properties where health claims can be supported with proper disclaimers. Paid acquisition is possible but requires more creative sophistication than most other categories.

3. The COGS advantage is real but can mask bad decisions

When your product costs $4 to make and sells for $40, it is easy to feel comfortable. That 90% gross margin gives the illusion of wide operating room. But once you add shipping ($3-$5), payment processing ($1.20-$1.60), acquisition cost ($15-$25 per order on a blended basis), and packaging ($2-$4), that $36 of gross profit becomes $0.40-$14.80 of contribution margin. The operating question to ask yourself: "If my gross margin dropped to 55% tomorrow, would my business still be profitable?" If the answer is no, then the high COGS margin is subsidizing a cost structure that needs to be fixed regardless.

4. Subscription retention is worth more than subscription acquisition

Adding 500 subscribers per month is meaningless if 400 are canceling. Every month a subscriber stays active, the effective CAC per order decreases and the lifetime value increases. The operating move that consistently outperforms adding more subscribers: investing in the subscription experience itself. Easy customization, skip/pause flexibility instead of cancel-only options, personal dosage guidance, and regular flavor or format drops that give existing subscribers a reason to stay engaged. The brands with the strongest subscription retention curves treat the subscriber experience as a product, and the brands stuck on the acquisition treadmill typically have not.